Endocrinology: Testosterone Replacement for Hypogonadism (Xavioer)

0.0(0)
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/47

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

48 Terms

1
New cards

What is testosterone replacement therapy primarily used to treat?

Hypogonadism in men

2
New cards

What are the characteristics of primary hypogonadism?

Low testosterone; elevated gonadotropin

3
New cards

What are the characteristics of secondary hypogonadism?

Low testosterone; low-normal gonadotropin

4
New cards

What are the characteristics of mixed hypogonadism?

Low testosterone; variable gonadotropin levels

5
New cards

When does the Endocrine Society recommend testosterone therapy?

For men with symptomatic testosterone deficiency to maintain secondary sex characteristics and correct hypogonadism symptoms.

6
New cards

What is the AUA's recommended cut-off for diagnosing low testosterone?

A total testosterone level below 300 ng/dL

7
New cards

How many total testosterone measurements are needed for diagnosing low testosterone?

Two measurements taken on separate occasions, both in the early morning

8
New cards

In which conditions should total testosterone be measured, even without symptoms of deficiency?

Unexplained anemia, bone density loss, diabetes, exposure to chemotherapy or testicular radiation, HIV/AIDS, chronic narcotic or corticosteroid use, male infertility, and pituitary dysfunction

9
New cards

Why are oral testosterone products not recommended as a first-line agent?

Due to the risk of hepatotoxicity

10
New cards

What is the initial dose of oral testosterone undecanoate (Jatenzo®)?

237 mg twice daily (BID) with food

11
New cards

When should the dose of Jatenzo® be adjusted?

Based on the AM testosterone level, taken 6 hours after the morning dose, 1 week after starting treatment

12
New cards

What are the available capsule strengths of Jatenzo®?

158 mg, 198 mg, and 237 mg

13
New cards

Is Jatenzo® recommended for age-related hypogonadism?

No

14
New cards

What is a side effect of intramuscular testosterone injections due to supraphysiologic serum concentrations?

Mood swings

15
New cards

What is the black box warning (BBW) for testosterone undecanoate injections?

Pulmonary oil microembolism (POME) reactions, including cough, shortness of breath (SOB), chest pain, and anaphylaxis

16
New cards

How is testosterone undecanoate available?

Only through a REMS (Risk Evaluation and Mitigation Strategy) program

17
New cards

How long should patients be monitored after a testosterone undecanoate injection?

For at least 30 minutes

18
New cards

What is the dosing frequency for subcutaneous testosterone enanthate?

Once-weekly subcutaneous injection

19
New cards

Are testosterone injections recommended for age-related hypogonadism?

No

20
New cards

How often should buccal testosterone be applied?

Twice daily, every 12 hours

21
New cards

How should buccal testosterone be applied?

Press against the gum for 30 seconds and rotate sides with each application

22
New cards

What is the strength of testosterone buccal tablets?

30 mg

23
New cards

What are common side effects of buccal testosterone?

Gum/mouth pain, irritation, and taste disturbance

24
New cards

How often should nasal testosterone (Natesto) be used?

One pump per nostril, three times daily

25
New cards

How much testosterone is delivered per actuation of Natesto?

5.5 mg per actuation

26
New cards

What are common side effects (ADRs) of nasal testosterone?

Nasal irritation, nosebleeds, rhinorrhea, and nasopharyngitis

27
New cards

What are the available dosages for testosterone cypionate, enanthate, and undecanoate?

  • Cypionate: 100 mg/mL and 200 mg/mL

  • Enanthate: 200 mg/mL

  • Undecanoate: 750 mg/3 mL

28
New cards

How long should you wait before reapplying the patch to the same site?

7 days

29
New cards

Where should testosterone gel (Testim) be applied?

Shoulders or upper arms only

30
New cards

What is the black box warning (BBW) for testosterone gel?

Secondary exposure — cover the application site with clothing to prevent transfer

31
New cards

How often should you rotate the application site for a testosterone patch?

Rotate the site with a 7-day interval before reapplying to the same area

32
New cards

Where should the transdermal spray be applied?

To the front or inner thighs only

33
New cards

Where should transdermal testosterone solution be applied?

To the armpit (axilla) only

34
New cards

What schedule are testosterone products classified as?

Schedule-III controlled substances

35
New cards

Who are testosterone products contraindicated for?

Men with breast or prostate cancer, and pregnant or breastfeeding women (or those who may become pregnant)

36
New cards

What is the black box warning (BBW) for oral testosterone undecanoate and subQ enanthate?

Increased blood pressure (BP)

37
New cards

In what cases should testosterone products be avoided due to caution or warnings?

In men with recent myocardial infarction (MI) or stroke within the past 6 months, and men with severe lower urinary tract symptoms (LUTS)

38
New cards

What is a common fluid-related adverse effect of testosterone products?

Fluid retention

39
New cards

What is the effect of testosterone products on hematocrit?

They can increase hematocrit, leading to polycythemia

40
New cards

In terms of metabolic effects, what will testosterone increase?

  • Insulin sensitivity

  • Glycemic control

  • Lean body mass

  • Muscle mass

  • Triglycerides; ↓ HDL-C

41
New cards

In terms of metabolic effects, what will testosterone decrease?

Subcutaneous fat

42
New cards

What prostate-specific antigen (PSA) level indicates that testosterone should not be initiated?

PSA >4 ng/mL, or >3 ng/mL if at high risk for prostate cancer

43
New cards

What hematocrit level indicates that testosterone should not be initiated?

Hematocrit >48%, or >50% in high-altitude areas

44
New cards

What ongoing monitoring is required once testosterone replacement therapy is stable?

Testosterone levels, CBC (hematocrit), PSA*, liver function, lipids, symptoms of low testosterone, and adverse effects of medication

<p>Testosterone levels, CBC (hematocrit), PSA*, liver function, lipids, symptoms of low testosterone, and adverse effects of medication</p>
45
New cards

When should testosterone therapy be discontinued based on PSA levels?

Discontinue if PSA increases by more than 1.4 ng/mL from baseline or if PSA is >4.0 ng/mL

46
New cards

What hematocrit level indicates that testosterone therapy should be discontinued?

Hematocrit >54%

47
New cards

What testosterone concentration level indicates discontinuation for products like Striant and Natesto?

Testosterone concentration >1050 ng/dL

48
New cards

When should you recheck testosterone levels after initiating?

See image

<p>See image</p>